Namita Agrawal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Namita Agrawal has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Akanksha Singh
Department of Zoology, University of Delhi, New Delhi, India
5 shared publications Akanksha Raj
Department of Zoology University of Delhi Delhi India
4 shared publicationsAkanksha Singh
Department of Zoology, University of Delhi, Delhi 110007, India
4 shared publications- Mallikarjun Shakarad
Department of Zoology, University of Delhi, Delhi, India
4 shared publications Prasanna Shah
Department of Physics Acropolis Institute of Technology and Research Indore India
4 shared publications- Anju Shrivastava
Department of Zoology, University of Delhi, Delhi 110007, India
2 shared publications
Latest Publications
- Open Access
Glial Mutant Huntingtin Initiates a Progressive Pathological Cascade Toward Neuronal Involvement in Drosophila
The mechanisms of involvement of glial cells in the progression of Huntington’s disease remain sparingly elucidated. Using the Drosophila melanogaster model, we investigated the temporal course of the disease pathogenesis induced by pan-glial expression of HTTex1pQ93 in comparison to the temporal course of pathology induced by pan-neuronal expression. Our behavioural data were supported by quantitative confocal microscopy, quantification of aggregate formation and its morphometry, Mander’s M2 colocalization index, and correlative holotomography. Expression of mHTT in glial cells led to developmental defects and subsequent delayed onset of motor dysfunction and death with increasing amounts of HTT and changes in the immunoreactivity of glial cells. In spite of the progressive increase in HTT accumulation, glial aggregates showed stability after their initial formation, while neuronal mHTT revealed distinct age-dependent remodelling of its aggregates. Importantly, there was an initial preference of glial mHTT for glial compartments followed by a progressively increasing number of HTT in the neurons with aging. Correlative holotomography provided spatial evidence of the neuronal association of HTT. Together, these findings demonstrate that glial mHTT establishes a distinct progressive pathological trajectory characterised by evolving glial pathology, increasing neuronal involvement, and delayed functional decline, highlighting glia as an active component of HD-like disease progression.
Open AccessGlial Mutant Huntingtin Initiates a Progressive Pathological Cascade Toward Neuronal Involvement in Drosophila
The mechanisms of involvement of glial cells in the progression of Huntington’s disease remain sparingly elucidated. Using the Drosophila melanogaster model, we investigated the temporal course of the disease pathogenesis induced by pan-glial expression of HTTex1pQ93 in comparison to the temporal course of pathology induced by pan-neuronal expression. Our behavioural data were supported by quantitative confocal microscopy, quantification of aggregate formation and its morphometry, Mander’s M2 colocalization index, and correlative holotomography. Expression of mHTT in glial cells led to developmental defects and subsequent delayed onset of motor dysfunction and death with increasing amounts of HTT and changes in the immunoreactivity of glial cells. In spite of the progressive increase in HTT accumulation, glial aggregates showed stability after their initial formation, while neuronal mHTT revealed distinct age-dependent remodelling of its aggregates. Importantly, there was an initial preference of glial mHTT for glial compartments followed by a progressively increasing number of HTT in the neurons with aging. Correlative holotomography provided spatial evidence of the neuronal association of HTT. Together, these findings demonstrate that glial mHTT establishes a distinct progressive pathological trajectory characterised by evolving glial pathology, increasing neuronal involvement, and delayed functional decline, highlighting glia as an active component of HD-like disease progression.
- Open Access
- 14 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0322707
A high throughput method for isolation of plasmatocytes from hemolymph of adult Drosophila
Macrophages are essential innate immune system components, exhibiting diverse functions crucial for disease prevention. While much is known about their role in innate immunity, studying their functional versatility remains a challenge. Drosophila serves as an excellent model for investigating innate immune signaling due to parallels with vertebrate macrophages. Despite extensive research on larval plasmatocytes, there is a lack of sufficient published literature on adult plasmatocytes, hindering understanding of their contribution to late-onset diseases and aging. Current hemolymph extraction protocols from adult flies have limitations, making them less suitable for immunology experiments that require consistency and minimal stress on flies. Most established methods involve specialized tools such as nanoinjectors, silica capillary probes, etc. which are arduous and require advanced equipment. Although these approaches overcome some challenges in immune cell research, they remain complex and technically intricate. Here, for the first time, we present a protocol for quick, easy, cost-effective, and systematic isolation of adult Drosophila plasmatocytes by which we achieve nearly 2500 cells. We strongly suggest that this protocol might facilitate studies aiming to elucidate molecular and genetic mechanisms associated with immune response in various ailments enabling the exploration of immune cell dynamics, cell signaling and their role in disease progression.
- 14 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0322707
Open AccessA high throughput method for isolation of plasmatocytes from hemolymph of adult Drosophila
Macrophages are essential innate immune system components, exhibiting diverse functions crucial for disease prevention. While much is known about their role in innate immunity, studying their functional versatility remains a challenge. Drosophila serves as an excellent model for investigating innate immune signaling due to parallels with vertebrate macrophages. Despite extensive research on larval plasmatocytes, there is a lack of sufficient published literature on adult plasmatocytes, hindering understanding of their contribution to late-onset diseases and aging. Current hemolymph extraction protocols from adult flies have limitations, making them less suitable for immunology experiments that require consistency and minimal stress on flies. Most established methods involve specialized tools such as nanoinjectors, silica capillary probes, etc. which are arduous and require advanced equipment. Although these approaches overcome some challenges in immune cell research, they remain complex and technically intricate. Here, for the first time, we present a protocol for quick, easy, cost-effective, and systematic isolation of adult Drosophila plasmatocytes by which we achieve nearly 2500 cells. We strongly suggest that this protocol might facilitate studies aiming to elucidate molecular and genetic mechanisms associated with immune response in various ailments enabling the exploration of immune cell dynamics, cell signaling and their role in disease progression.
- Open Access
- 13 October 2024
- Published by SAGE Publications in Dose-Response
- Vol. 22 (4)
Neuroprotective Potential of Eugenol in Polyglutamine-Mediated Neurodegenerative Disease Using Transgenic Drosophila Model
Polyglutamine (PolyQ) diseases including Huntington’s disease are devastating neurodegenerative disorders characterized by progressive neuronal loss and motor dysfunction. PolyQ pathology involves multiple cellular events and phytochemicals with multi-target mechanisms hold promise to treat these diseases with least side effects. One such promising phytochemical is Eugenol, which possesses antioxidant and anti-inflammatory properties, potentially targeting disrupted cellular pathways in PolyQ diseases. The present study investigated the effects of Eugenol on neurodegeneration and motor dysfunction in transgenic Drosophila models of PolyQ diseases. In this study, the robust pseudopupil assay was performed to analyze adult photoreceptor neuron degeneration, a marker of widespread degenerative events. Furthermore, the well-established crawling and climbing assays were conducted to evaluate progressive motor dysfunction in the PolyQ larvae and flies. This study found that Eugenol administration at disease onset or after progression reduced PolyQ disease phenotypes, particularly, neurodegeneration and motor dysfunction in a dose-dependent manner and with no side effects. Thus, this study suggests that Eugenol could be a viable candidate for developing treatments for PolyQ diseases, offering a multi-target approach with the potential for minimal or no side effects compared to conventional therapies.
- 13 October 2024
- Published by SAGE Publications in Dose-Response
- Vol. 22 (4)
Open AccessNeuroprotective Potential of Eugenol in Polyglutamine-Mediated Neurodegenerative Disease Using Transgenic Drosophila Model
Polyglutamine (PolyQ) diseases including Huntington’s disease are devastating neurodegenerative disorders characterized by progressive neuronal loss and motor dysfunction. PolyQ pathology involves multiple cellular events and phytochemicals with multi-target mechanisms hold promise to treat these diseases with least side effects. One such promising phytochemical is Eugenol, which possesses antioxidant and anti-inflammatory properties, potentially targeting disrupted cellular pathways in PolyQ diseases. The present study investigated the effects of Eugenol on neurodegeneration and motor dysfunction in transgenic Drosophila models of PolyQ diseases. In this study, the robust pseudopupil assay was performed to analyze adult photoreceptor neuron degeneration, a marker of widespread degenerative events. Furthermore, the well-established crawling and climbing assays were conducted to evaluate progressive motor dysfunction in the PolyQ larvae and flies. This study found that Eugenol administration at disease onset or after progression reduced PolyQ disease phenotypes, particularly, neurodegeneration and motor dysfunction in a dose-dependent manner and with no side effects. Thus, this study suggests that Eugenol could be a viable candidate for developing treatments for PolyQ diseases, offering a multi-target approach with the potential for minimal or no side effects compared to conventional therapies.
- 13 August 2024
- Published by Springer Nature
- p. 29-53
Mechanism Underlying Major Neurodegenerative Disorders
- 13 August 2024
- Published by Springer Nature
- p. 29-53
Mechanism Underlying Major Neurodegenerative Disorders
- 19 September 2022
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 37 (8) , 2783-2792
Progressive transcriptional changes in metabolic genes and altered fatbody homeostasis in Drosophila model of Huntington’s disease
Huntington’s disease (HD) is an autosomal-dominant neurodegenerative disorder marked by progressive neuronal atrophy, particularly in striatum and cerebral cortex. Although predominant manifestations of the disease include loss in the triad of motor, cognitive and behavioral capabilities, metabolic dysfunction in patients and HD models are being increasingly recognized. Patients display progressive body weight loss, which aggravates the disease and leads to cachexia in the terminal stages. Using the Drosophila model of HD, we have earlier reported that diseased flies exhibit an atypical pattern of lipid gain and loss with progression along with exhibiting extensive mitochondrial dysfunction, impaired calcium homeostasis and heightened apoptosis in the fatbody. Here, we first monitored the structural changes that abdominal fatbody undergoes with disease progression. Further, we checked the transcriptional changes of key metabolic genes in whole fly as well as genes regulating mitochondrial function, apoptosis, autophagy and calcium homeostasis in the abdominal fatbody. We found extensive alterations in whole-body and fatbody-specific transcriptional profile of the diseased flies, which was in consort with their stage-specific physiological state. Additionally, we also assessed lysosome-mediated autophagy in the fatbody of diseased flies in order to ascertain the mechanisms contributing to fatbody atrophy at the terminal stage. Interestingly, we found elevated autophagy in fatbody of flies throughout disease progression. This study provides new insights into the effect on peripheral metabolism due to degeneration of neurons in the neurodegenerative disease, thereby discerns novel mechanisms leading to cachexia in diseased flies and advocates for the need of managing metabolic dysfunctions in HD.
- 19 September 2022
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 37 (8) , 2783-2792
Progressive transcriptional changes in metabolic genes and altered fatbody homeostasis in Drosophila model of Huntington’s disease
Huntington’s disease (HD) is an autosomal-dominant neurodegenerative disorder marked by progressive neuronal atrophy, particularly in striatum and cerebral cortex. Although predominant manifestations of the disease include loss in the triad of motor, cognitive and behavioral capabilities, metabolic dysfunction in patients and HD models are being increasingly recognized. Patients display progressive body weight loss, which aggravates the disease and leads to cachexia in the terminal stages. Using the Drosophila model of HD, we have earlier reported that diseased flies exhibit an atypical pattern of lipid gain and loss with progression along with exhibiting extensive mitochondrial dysfunction, impaired calcium homeostasis and heightened apoptosis in the fatbody. Here, we first monitored the structural changes that abdominal fatbody undergoes with disease progression. Further, we checked the transcriptional changes of key metabolic genes in whole fly as well as genes regulating mitochondrial function, apoptosis, autophagy and calcium homeostasis in the abdominal fatbody. We found extensive alterations in whole-body and fatbody-specific transcriptional profile of the diseased flies, which was in consort with their stage-specific physiological state. Additionally, we also assessed lysosome-mediated autophagy in the fatbody of diseased flies in order to ascertain the mechanisms contributing to fatbody atrophy at the terminal stage. Interestingly, we found elevated autophagy in fatbody of flies throughout disease progression. This study provides new insights into the effect on peripheral metabolism due to degeneration of neurons in the neurodegenerative disease, thereby discerns novel mechanisms leading to cachexia in diseased flies and advocates for the need of managing metabolic dysfunctions in HD.
- Open Access
- 10 May 2022
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 13 (2) , 54
An In Vitro and In Vivo Study of the Efficacy and Toxicity of Plant-Extract-Derived Silver Nanoparticles
Silver nanoparticles (AgNPs) display unique plasmonic and antimicrobial properties, enabling them to be helpful in various industrial and consumer products. However, previous studies showed that the commercially acquired silver nanoparticles exhibit toxicity even in small doses. Hence, it was imperative to determine suitable synthesis techniques that are the most economical and least toxic to the environment and biological entities. Silver nanoparticles were synthesized using plant extracts and their physico-chemical properties were studied. A time-dependent in vitro study using HEK-293 cells and a dose-dependent in vivo study using a Drosophila model helped us to determine the correct synthesis routes. Through biological analyses, we found that silver nanoparticles’ cytotoxicity and wound-healing capacity depended on size, shape, and colloidal stability. Interestingly, we observed that out of all the synthesized AgNPs, the ones derived from the turmeric extract displayed excellent wound-healing capacity in the in vitro study. Furthermore, the same NPs exhibited the least toxic effects in an in vivo study of ingestion of these NPs enriched food in Drosophila, which showed no climbing disability in flies, even at a very high dose (250 mg/L) for 10 days. We propose that stabilizing agents played a superior role in establishing the bio-interaction of nanoparticles. Our study reported here verified that turmeric-extract-derived AgNPs displayed biocompatibility while exhibiting the least cytotoxicity.
- 10 May 2022
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 13 (2) , 54
Open AccessAn In Vitro and In Vivo Study of the Efficacy and Toxicity of Plant-Extract-Derived Silver Nanoparticles
Silver nanoparticles (AgNPs) display unique plasmonic and antimicrobial properties, enabling them to be helpful in various industrial and consumer products. However, previous studies showed that the commercially acquired silver nanoparticles exhibit toxicity even in small doses. Hence, it was imperative to determine suitable synthesis techniques that are the most economical and least toxic to the environment and biological entities. Silver nanoparticles were synthesized using plant extracts and their physico-chemical properties were studied. A time-dependent in vitro study using HEK-293 cells and a dose-dependent in vivo study using a Drosophila model helped us to determine the correct synthesis routes. Through biological analyses, we found that silver nanoparticles’ cytotoxicity and wound-healing capacity depended on size, shape, and colloidal stability. Interestingly, we observed that out of all the synthesized AgNPs, the ones derived from the turmeric extract displayed excellent wound-healing capacity in the in vitro study. Furthermore, the same NPs exhibited the least toxic effects in an in vivo study of ingestion of these NPs enriched food in Drosophila, which showed no climbing disability in flies, even at a very high dose (250 mg/L) for 10 days. We propose that stabilizing agents played a superior role in establishing the bio-interaction of nanoparticles. Our study reported here verified that turmeric-extract-derived AgNPs displayed biocompatibility while exhibiting the least cytotoxicity.
- Open Access
- 9 February 2022
- Published by Elsevier in SSRN Electronic Journal
Progressive Transcriptional Changes of Key Metabolic Genes and Altered Fatbody Homeostasis in Drosophila Model of Huntington's Disease
Progressive body weight loss independent of caloric intake presents a major challenge for management of Huntington’s disease. Using Drosophila model of HD, we earlier reported that diseased flies exhibit an atypical pattern of lipid gain and loss, and their fatbody exhibits extensive mitochondrial dysfunction, impaired calcium homeostasis and heightened apoptosis with progression. Here, we aimed to further decipher key cellular and molecular processes in fatbody of diseased flies which contribute to maintain its integrity. Using the transgenic Drosophila HD model, we studied the morphology of fatbody with progression. Further, we monitored transcriptional changes of key metabolic genes in whole fly along with genes regulating mitochondrial function, apoptosis, autophagy and calcium homeostasis in the abdominal fatbody. Additionally, we assessed lysosome-mediated autophagy in the fatbody of diseased flies with progression. We found that the fatbody of HD flies undergoes a dynamic change in morphology, which corresponds to alteration in lipid content. Extensive alterations in whole-body and fatbody-specific transcriptional profile of the diseased flies, which was in consort with their stage-specific physiological manifestations were documented. Interestingly, we found the fatbody of diseased flies show enhanced autophagy from early stage onwards. This study highlights novel transcriptional changes in whole body and fatbody of HD flies and implies a role of induced autophagy in a peripheral tissue i.e., fatbody, upon neuronal expression of mutant huntingtin. Therefore, we provide insights into novel mechanisms leading to cachexia in flies and reiterate the need for managing metabolic dysfunctions in HD.
- 9 February 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessProgressive Transcriptional Changes of Key Metabolic Genes and Altered Fatbody Homeostasis in Drosophila Model of Huntington's Disease
Progressive body weight loss independent of caloric intake presents a major challenge for management of Huntington’s disease. Using Drosophila model of HD, we earlier reported that diseased flies exhibit an atypical pattern of lipid gain and loss, and their fatbody exhibits extensive mitochondrial dysfunction, impaired calcium homeostasis and heightened apoptosis with progression. Here, we aimed to further decipher key cellular and molecular processes in fatbody of diseased flies which contribute to maintain its integrity. Using the transgenic Drosophila HD model, we studied the morphology of fatbody with progression. Further, we monitored transcriptional changes of key metabolic genes in whole fly along with genes regulating mitochondrial function, apoptosis, autophagy and calcium homeostasis in the abdominal fatbody. Additionally, we assessed lysosome-mediated autophagy in the fatbody of diseased flies with progression. We found that the fatbody of HD flies undergoes a dynamic change in morphology, which corresponds to alteration in lipid content. Extensive alterations in whole-body and fatbody-specific transcriptional profile of the diseased flies, which was in consort with their stage-specific physiological manifestations were documented. Interestingly, we found the fatbody of diseased flies show enhanced autophagy from early stage onwards. This study highlights novel transcriptional changes in whole body and fatbody of HD flies and implies a role of induced autophagy in a peripheral tissue i.e., fatbody, upon neuronal expression of mutant huntingtin. Therefore, we provide insights into novel mechanisms leading to cachexia in flies and reiterate the need for managing metabolic dysfunctions in HD.
- 1 February 2022
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 363, 577801
Pan-neuronal expression of human mutant huntingtin protein in Drosophila impairs immune response of hemocytes
- 1 February 2022
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 363, 577801
Pan-neuronal expression of human mutant huntingtin protein in Drosophila impairs immune response of hemocytes
- 7 November 2021
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 247 (2) , 152-164
Management of altered metabolic activity in Drosophila model of Huntington’s disease by curcumin
Huntington’s disease (HD) is a devastating polyglutamine disorder characterized by extensive neurodegeneration and metabolic abnormalities at systemic, cellular and intracellular levels. Metabolic alterations in HD manifest as abnormal body weight, dysregulated biomolecule levels, impaired adipocyte functions, and defective energy state which exacerbate disease progression and pose acute threat to the health of challenged individuals in form of insulin resistance, cardiovascular disease, and energy crisis. To colossally mitigate disease symptoms, we tested the efficacy of curcumin in Drosophila model of HD. Curcumin is the bioactive component of turmeric (Curcuma longa Linn), well-known for its ability to modulate metabolic activities. We found that curcumin effectively managed abnormal body weight, dysregulated lipid content, and carbohydrate level in HD flies. In addition, curcumin administration lowered elevated reactive-oxygen-species levels in adult adipose tissue of diseased flies, and improved survival and locomotor function in HD flies at advanced disease stage. Altogether, these findings clearly suggest that curcumin efficiently attenuates metabolic derangements in HD flies and can prove beneficial in alleviating the complexities associated with HD.
- 7 November 2021
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 247 (2) , 152-164
Management of altered metabolic activity in Drosophila model of Huntington’s disease by curcumin
Huntington’s disease (HD) is a devastating polyglutamine disorder characterized by extensive neurodegeneration and metabolic abnormalities at systemic, cellular and intracellular levels. Metabolic alterations in HD manifest as abnormal body weight, dysregulated biomolecule levels, impaired adipocyte functions, and defective energy state which exacerbate disease progression and pose acute threat to the health of challenged individuals in form of insulin resistance, cardiovascular disease, and energy crisis. To colossally mitigate disease symptoms, we tested the efficacy of curcumin in Drosophila model of HD. Curcumin is the bioactive component of turmeric (Curcuma longa Linn), well-known for its ability to modulate metabolic activities. We found that curcumin effectively managed abnormal body weight, dysregulated lipid content, and carbohydrate level in HD flies. In addition, curcumin administration lowered elevated reactive-oxygen-species levels in adult adipose tissue of diseased flies, and improved survival and locomotor function in HD flies at advanced disease stage. Altogether, these findings clearly suggest that curcumin efficiently attenuates metabolic derangements in HD flies and can prove beneficial in alleviating the complexities associated with HD.